임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
11건 표시
- 3상모집 중단 (진행 중)· Non-small Cell Lung Cancer Stage IVA Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer
리드: 삼성바이오에피스
- 3상완료· Postmenopausal OsteoporosisA Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis
리드: 삼성바이오에피스
- 3상완료· Neovascular Age-related Macular DegenerationA Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)
리드: 삼성바이오에피스
- 3상완료· Paroxysmal Nocturnal HemoglobinuriaA Study to Compare SB12 (Proposed Eculizumab Biosimilar) to Soliris in Subjects With Paroxysmal Nocturnal Haemoglobinuria
리드: 삼성바이오에피스
- 3상완료· Age-Related Macular DegenerationA Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)
리드: 삼성바이오에피스
- 3상완료· Lung CancerA Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
리드: 삼성바이오에피스
- 3상완료· Rheumatoid ArthritisA Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
리드: 삼성바이오에피스
- 3상완료· HER2 Positive Early or Locally Advanced Breast CancerA Study to Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer
리드: 삼성바이오에피스
- 3상완료· Rheumatoid ArthritisA Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
리드: 삼성바이오에피스
- 3상완료· Rheumatoid ArthritisA Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
리드: 삼성바이오에피스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.